AZAINDAZOLE AMIDE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS

Disclosed are CCR1 inhibitor compounds of the formula (I): which are useful in the treatment of autoimmune and other diseases. Also disclosed a pharmaceutical compositions containing the same, and methods of making and using same. L'invention concerne des composés inhibiteurs des récepteurs CCR...

Full description

Saved in:
Bibliographic Details
Main Author HUBER, JOHN DAVID
Format Patent
LanguageEnglish
French
Published 03.11.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are CCR1 inhibitor compounds of the formula (I): which are useful in the treatment of autoimmune and other diseases. Also disclosed a pharmaceutical compositions containing the same, and methods of making and using same. L'invention concerne des composés inhibiteurs des récepteurs CCR1 de la formule (I) qui sont utiles dans le traitement de maladies auto-immunes et autres. L'invention concerne également des compositions pharmaceutiques contenant ces composés, ainsi que leurs procédés de fabrication et d'utilisation.
Bibliography:Application Number: WO2011US33923